TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT06748586 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06748586 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT05432167 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05990491 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT06750341 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06750341 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05447325 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT05755581 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05755581 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04618094 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04947189 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05543317 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05853224 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06209619 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05902741 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05902741 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06507618 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05126303 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04186416 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02258490 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06154252 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05507242 — Predictive Biomarker (PRD): TSLP mRNA
Genes: TSLP
Study NCT05749822 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study NCT06350110 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06350110 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06517654 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT06439602 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT05674955 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06312176 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06312176 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06312176 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06312176 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06368206 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06174402 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study NCT06457958 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT05481333 — Predictive Biomarker (PRD): TMPRSS6 mRNA
Genes: TMPRSS6; UNQ354/PRO618
Study NCT04347135 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT06152172 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06616987 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06623630 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04701242 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06707025 — Predictive Biomarker (PRD): CD24 mRNA
Genes: CD24; CD24A
Study NCT06707025 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-122
Genes: MIR122
Study NCT06749223 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT06749730 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT06749886 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06749886 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06749886 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT06751394 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04034901 — Predictive Biomarker (PRD): BORA mRNA
Genes: BORA; C13orf34
Study NCT06750159 — Predictive Biomarker (PRD): AKR1B10 mRNA
Genes: AKR1B10; AKR1B11
Study NCT04014348 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06573801 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04862780 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06029647 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05954884 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04910867 — Predictive Biomarker (PRD): APOL1 mRNA
Genes: APOL1; APOL
Study NCT05663619 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04390282 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05044897 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT06489015 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT06089603 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT05593939 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05593939 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05593939 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05291910 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06563882 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06044792 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06283212 — Predictive Biomarker (PRD): SCN1A mRNA
Genes: SCN1A; NAC1; SCN1
Study NCT06478459 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT06145087 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05618028 — Predictive Biomarker (PRD): MALT1 mRNA
Genes: MALT1; MLT
Study NCT05618028 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04835805 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT06154590 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05245851 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05532800 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT04980248 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05845749 — Surrogate Endpoint (SUR): Annualized growth velocity
Study NCT04689828 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05852431 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05057013 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT04716725 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06584656 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04858217 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04858217 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06317844 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT05102370 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT06526273 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06353958 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT05075031 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT05075031 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04836793 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04873934 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06487975 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT06726941 — Predictive Biomarker (PRD): ZMYM2 mRNA
Genes: ZMYM2; FIM; RAMP; ZNF198
Study NCT06726941 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT06745804 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06743828 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04989803 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04871607 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT06103240 — Surrogate Endpoint (SUR): Bacterial count
Study NCT05861843 — Predictive Biomarker (PRD): EDA mRNA
Genes: EDA; ED1; EDA2
Study NCT00365027 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT06307457 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06307457 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06307457 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06307457 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05980702 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04669067 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT04669067 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT04956887 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06363760 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06174571 — Predictive Biomarker (PRD): PAPPA mRNA
Genes: PAPPA
Study NCT05644080 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05918211 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT05827926 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05279690 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05928988 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04656561 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06288152 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT06172140 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06557304 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05061212 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT05886049 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05965219 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06428396 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06428396 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06333951 — Predictive Biomarker (PRD): MTAP mRNA
Genes: MTAP; MSAP
Study NCT05726864 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05726864 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT04972201 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05337657 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05337657 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05095467 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT05723991 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05534646 — Predictive Biomarker (PRD): ARSI mRNA
Genes: ARSI
Study NCT06402825 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06402825 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04908982 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06700044 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06750484 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06749860 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06750991 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05969730 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT05969730 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT04729296 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06750848 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06750848 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06750848 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06750042 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06750315 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06751303 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT05176223 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05609578 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04120766 — Predictive Biomarker (PRD): ABCC9 mRNA
Genes: ABCC9; SUR2
Study NCT06289257 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05451082 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04884802 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04700007 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT05527769 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study NCT05839288 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05282121 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05194995 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05819359 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study NCT05016271 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05825170 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06291987 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT05308446 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06609928 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT06634875 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study NCT05761366 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04820621 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06105918 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05642338 — Predictive Biomarker (PRD): HGD mRNA
Genes: HGD; HGO
Study NCT06526949 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06628817 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05954507 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT00268047 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT06067178 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05037266 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06534411 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04822103 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06312137 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04426591 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05154734 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT06563765 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT04459468 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study NCT05106036 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05757193 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05256290 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05256290 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06022926 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04585958 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04874012 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT06253871 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00496171 — Predictive Biomarker (PRD): HAL mRNA
Genes: HAL; HIS
Study NCT06702618 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06702618 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06702618 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06702618 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06702618 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06717659 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06717659 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06717659 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06745037 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06747338 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06748508 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06748898 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05856396 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04870983 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study NCT04167917 — Predictive Biomarker (PRD): DNMT1 mRNA
Genes: DNMT1; AIM; CXXC9; DNMT
Study NCT06188988 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT04820023 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04820023 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06247137 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06247137 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06247137 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06247137 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05674370 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05463354 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04781491 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06331754 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04889261 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04889261 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT05787444 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05223036 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05162248 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT05589454 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT05589454 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05589454 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT06055439 — Predictive Biomarker (PRD): CDH17 mRNA
Genes: CDH17
Study NCT04976634 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT06411938 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05689021 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT04749628 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05377684 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05377684 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05377684 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05377684 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06404034 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study NCT06404034 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05283044 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study NCT05148572 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT06053138 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study NCT06053138 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05818800 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05558904 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05563220 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05253131 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT05382559 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06153966 — Pharmacodynamic Biomarker (PDY): Major prion protein
Genes: PRNP; ALTPRP; PRIP; PRP
Study NCT05488340 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT06453577 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06225206 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05023109 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT03271515 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05934526 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05687344 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06710990 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06705764 — Predictive Biomarker (PRD): TSLP mRNA
Genes: TSLP
Study NCT06748521 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT06748612 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06750952 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06335836 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT06551649 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05440617 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study NCT04603014 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04603014 — Surrogate Endpoint (SUR): Serum sodium
Study NCT06630104 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06630104 — Predictive Biomarker (PRD): RAPH1 mRNA
Genes: RAPH1; ALS2CR18; ALS2CR9; KIAA1681; LPD; PREL2; RMO1
Study NCT06457568 — Surrogate Endpoint (SUR): Blood pressure